Inhibitor Therapeutics, Inc. Share Price
Equities
INTI
US45720M1053
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.086 USD | +0.23% | +25.55% | -6.52% |
03-29 | Inhibitor Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Introducing Inhibitor Therapeutics, Inc. Announces Scientific Advisory Board | CI |
Sales 2022 | - | Sales 2023 | - | Capitalization | 15.83M 1.26B |
---|---|---|---|---|---|
Net income 2022 | 12M 957M | Net income 2023 | -3M -239M | EV / Sales 2022 | - |
Net cash position 2022 | 11.54M 920M | Net cash position 2023 | 8.84M 705M | EV / Sales 2023 | - |
P/E ratio 2022 |
3.29
x | P/E ratio 2023 |
-4.6
x | Employees | 6 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 41.51% |
1 day | +0.23% | ||
1 week | +25.55% | ||
Current month | +22.86% | ||
1 month | +22.86% | ||
3 months | -14.00% | ||
6 months | +66.99% | ||
Current year | -6.52% |
Date | Price | Change | Volume |
---|---|---|---|
29/04/24 | 0.086 | +0.23% | 1,250 |
24/04/24 | 0.0858 | +50.53% | 250 |
Delayed Quote OTC Markets, April 29, 2024 at 08:44 pm
More quotes1st Jan change | Capi. | |
---|---|---|
-6.52% | 14.79M | |
-2.63% | 102B | |
+1.62% | 96.29B | |
+1.46% | 22.18B | |
-16.67% | 21.2B | |
-8.58% | 18.31B | |
-38.74% | 17.38B | |
-13.21% | 16.36B | |
+5.41% | 13.97B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- INTI Stock